
Sign up to save your podcasts
Or


In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.
By NEJM Group4.7
3131 ratings
In the face of a growing childhood obesity epidemic, some parents and clinicians are turning to new tools such as GLP-1 receptor agonists. This episode explores the implications of that trend.
A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400703.

38,460 Listeners

38,737 Listeners

7,685 Listeners

320 Listeners

128 Listeners

497 Listeners

1,427 Listeners

57 Listeners

3,342 Listeners

1,153 Listeners

90 Listeners

5 Listeners

194 Listeners

365 Listeners

6,060 Listeners

370 Listeners

58 Listeners

56 Listeners